Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Migraine Article COVID-19 - crisis and migraine management? Depression Article Does glutamate hold the key to unlocking major depressive disorder? Schizophrenia Article Complementary approaches for improving outcomes in first-episode psychosis